1. 184PCAM-H2 effectively targets and treats HER2 positive brain lesions: A comparative preclinical study with trastuzumab. (13th May 2019) Authors: Puttemans, J; D'Huyvetter, M; Windhorst, B; Lahoutte, T; Devoogdt, N Journal: Annals of oncology Issue: Volume 30(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 85TiPPhase II trial of HER2-PET/CT using 68Ga-anti-HER2 VHH1 for characterization of HER2 presence in brain metastases of breast cancer patients. (13th May 2019) Authors: Keyaerts, M; Xavier, C; Everaert, H; Vaneycken, I; Fontaine, C; Decoster, L; Vanhoeij, M; Caveliers, V; Lahoutte, T Journal: Annals of oncology Issue: Volume 30(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗